F
Fresenius Medical Care AG (FMS)
NYQ – Real Time Price. Currency in USD
23.24
-0.01 (-0.04%)
At close: Jun 26, 2026, 4:00 PM EDT
23.69
+0.45 (1.94%)
After-hours: Jun 26, 2026, 6:40 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
23.24
-0.01 (-0.04%)
At close: Jun 26, 2026, 4:00 PM EDT
23.69
+0.45 (1.94%)
After-hours: Jun 26, 2026, 6:40 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.20 | 1.59 | 7.0 | |
| Quick ratio | 0.86 | 1.27 | 5.0 | |
| Debt to Equity | 0.83 | 0.27 | 6.0 | |
| Debt to Assets | 0.35 | 0.72 | 6.0 | |
| Interest coverage | 5.37 | 25.51 | 10 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 20.38B | 21.03B | 20.92B | 22.16B | 22.44B |
| Gross Profit | 5.58B | 5.33B | 5.15B | 5.69B | 5.82B |
| Operating Income | 1.84B | 1.72B | 1.78B | 2.13B | 2.29B |
| Net Income | 708M | 539M | 582M | 1.10B | 1.09B |
| EBITDA | 3.65B | 3.46B | 3.44B | 3.78B | 3.97B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -0.58 | 15.14 | 5.0 |
| Next quarter | 1.73 | 2.19 | 3.0 |
| Current year | -2.65 | -8.44 | 1.0 |
| Next year | 3.39 | 8.95 | 5.0 |
| Weighted average score | 3.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -8.55 | -63.86 | -37.16 | -93.49 | 1.0 |
| Y/Y | 5.03 | -13.6 | 11.8 | 278.15 | 5.8 |
| 3y average | 2.86 | 24.62 | 18.67 | 11.53 | 7.5 |
| 5y average | 1.75 | 4.39 | 2.1 | -6.71 | 2.8 |
| Weighted average score | 4.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 3.33 | 3.33 | 8.0 |
| Payout ratio | 32.32 | 32.32 | 5.0 |
| 5-year dividend growth rate | 2.60 | 2.60 | 4.0 |
| Years of dividend increase | 2.00 | 2.00 | 3.0 |
| Weighted average score | 5.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 9.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Wide | 9.0 |
| Network effect | Narrow | 4.0 |
| Economies of scale | Wide | 9.0 |
| Weighted average score | 7.8 | |
Total debt $12.7B significantly exceeds cash reserves ($1.4B), raising financial stability concerns
Total current assets $9.3B exceed Total current liabilities $7.8B, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (5x) indicates the company easily manages its debt payments
The company generates positive free cash flow $43.1M, supporting its financial health